BiotechTube
Home/TikkunLev Therapeutics/Robin Shaw, M.D., Ph.D.
RS

Robin Shaw, M.D., Ph.D.

CSO and Co-Founder

TikkunLev Therapeutics

Therapeutic Areas

Cardiovascular DiseaseHeart Failure

TikkunLev Therapeutics Pipeline

DrugIndicationPhase
TLT-101Heart FailurePre-clinical

Leadership Team at TikkunLev Therapeutics

DS
Darryl Shaw, MBA, CPA
Interim CEO and Co-Founder
AM
Andra Miller, Ph.D.
Advisor, Gene Therapy CMC
SR
Steve Rosen, Ph.D.
Advisor, Business Development
View full TikkunLev Therapeutics profile